Document is current
Any future updates will be listed below
-
Authors
Wild, Léa
Beele, Alicia
Seguchi, Masaru
Lenz, Tobias
Nicol, Philipp
Sabic-Halilcevic, Emina
Klosterman, Grace R.
Kastrati, Adnan
Joner, Michael https://orcid.org/0000-0002-2971-8310
-
Funding
Funding for this research was provided by:
Translumina GmbH
Deutsches Herzzentrum München
- License Information
-
More Information
Article History
Received: 6 May 2025
Accepted: 1 August 2025
First Online: 15 August 2025
Declarations
: No human studies were carried out by the authors for this article.
: All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
: Not applicable.
: L.W. received honoraria for a speaking engagement from Translumina GmbH. M.S. reports honoraria from Amgen, Biotronik, Kowa, NIPRO and Novartis, not related to the current work. A.K. reports participation on the data safety monitoring/advisory board TARGET IV funded by CRF New York, as well as issued patent PCT/EP2021/053116 and an applied patent regarding DES technology, not related to the current work. M.J. received personal fees from Abbot, Alchimedics S.A.S, Astra Zeneca, Biotronik, Medtronic, Recor, TriCares and Veryan, as well as grants and personal fees from Boston Scientific and Edwards outside the submitted work. All other authors have nothing to disclose and have no competing interests.
